Evaluation of serum fibronectin levels and fibronectin gene polymorphism in patients receiving intravesical BCG therapy for non-muscle invasive bladder cancer and its prognostic value
Abstract Background Bladder cancer continues to be a significant health issue, leading to ongoing research into novel biomarkers and treatment strategies. This study aims to evaluate the potential of serum fibronectin levels and fibronectin gene polymorphisms as biomarkers for predicting the recurre...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2024-09-01
|
| Collection: | BMC Urology |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s12894-024-01592-8 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|